{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T21:11:39Z","timestamp":1788901899286,"version":"build-2803163510"},"reference-count":126,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.cca.2026.121184","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:14:18Z","timestamp":1781626458000},"page":"121184","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Irisin as a multi-target renoprotective mediator in chronic kidney disease: from molecular mechanisms to therapeutic perspectives"],"prefix":"10.1016","volume":"592","author":[{"given":"Shubhdeep Singh","family":"Bandral","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sapna","family":"Ahuja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thakur Gurjeet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupinder","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.cca.2026.121184_bb0005","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1161\/CIRCULATIONAHA.120.050686","article-title":"Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options","volume":"143","author":"Jankowski","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2026.121184_bb0010","doi-asserted-by":"crossref","first-page":"17088","DOI":"10.1038\/nrdp.2017.88","article-title":"Chronic kidney disease","volume":"3","author":"Romagnani","year":"2017","journal-title":"Nat. Rev. Dis. Primers."},{"issue":"1","key":"10.1016\/j.cca.2026.121184_bb0015","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.kisu.2021.11.003","article-title":"Epidemiology of chronic kidney disease: an update 2022","volume":"12","author":"Kovesdy","year":"2022","journal-title":"Kidney Int. Suppl."},{"issue":"10225","key":"10.1016\/j.cca.2026.121184_bb0020","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","article-title":"Global, regional, and national burden of chronic kidney disease, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"395","author":"Bikbov","year":"2020","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.cca.2026.121184_bb0025","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.kint.2017.09.033","article-title":"Renal tubule injury: a driving force toward chronic kidney disease","volume":"93","author":"Liu","year":"2018","journal-title":"Kidney Int."},{"key":"10.1016\/j.cca.2026.121184_bb0030","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1146\/annurev-physiol-022516-034227","article-title":"Mechanisms of renal fibrosis","volume":"80","author":"Humphreys","year":"2018","journal-title":"Annu. Rev. Physiol."},{"issue":"5","key":"10.1016\/j.cca.2026.121184_bb0035","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41581-019-0248-y","article-title":"Targeting the progression of chronic kidney disease","volume":"16","author":"Ruiz-Ortega","year":"2020","journal-title":"Nat. Rev. Nephrol."},{"issue":"8","key":"10.1016\/j.cca.2026.121184_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21082951","article-title":"Roles of Nrf2 in protecting the kidney from oxidative damage","volume":"21","author":"Nezu","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.cca.2026.121184_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/toxins14040280","article-title":"Uremic toxins and cardiovascular risk in chronic kidney disease: what have we learned recently beyond the past findings?","volume":"14","author":"El Chamieh","year":"2022","journal-title":"Toxins (Basel)"},{"issue":"5","key":"10.1016\/j.cca.2026.121184_bb0050","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ni.1863","article-title":"The role of pattern-recognition receptors in innate immunity: update on toll-like receptors","volume":"11","author":"Kawai","year":"2010","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.cca.2026.121184_bb0055","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/kisup.2014.7","article-title":"Macrophages promote renal fibrosis through direct and indirect mechanisms","volume":"4","author":"Nikolic-Paterson","year":"2014","journal-title":"Kidney Int. Suppl."},{"issue":"9","key":"10.1016\/j.cca.2026.121184_bb0060","article-title":"The role of oxidative stress in kidney injury","volume":"12","author":"Piko","year":"2023","journal-title":"Antioxidants (Basel)"},{"issue":"6","key":"10.1016\/j.cca.2026.121184_bb0065","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nrendo.2016.221","article-title":"Physiology and role of irisin in glucose homeostasis","volume":"13","author":"Perakakis","year":"2017","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.cca.2026.121184_bb0070","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.peptides.2014.03.021","article-title":"Three new players in energy regulation: preptin, adropin and irisin","volume":"56","author":"Aydin","year":"2014","journal-title":"Peptides"},{"issue":"7","key":"10.1016\/j.cca.2026.121184_bb0075","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/j.cell.2018.10.025","article-title":"Irisin mediates effects on bone and fat via alphaV integrin receptors","volume":"175","author":"Kim","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.cca.2026.121184_bb0080","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.rvsc.2022.08.025","article-title":"Irisin promotes the browning of white adipocytes tissue by AMPKalpha1 signaling pathway","volume":"152","author":"Luo","year":"2022","journal-title":"Res. Vet. Sci."},{"issue":"1","key":"10.1016\/j.cca.2026.121184_bb0085","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s43088-025-00643-9","article-title":"Role of irisin in metabolic and cardiovascular disorders and its therapeutic potential","volume":"14","author":"Khalil","year":"2025","journal-title":"Beni-Suef University Journal of Basic and Applied Sciences"},{"issue":"9","key":"10.1016\/j.cca.2026.121184_bb0090","doi-asserted-by":"crossref","DOI":"10.3390\/jcdd9090305","article-title":"Irisin, an effective treatment for cardiovascular diseases?","volume":"9","author":"Liu","year":"2022","journal-title":"J Cardiovasc Dev Dis"},{"issue":"6","key":"10.1016\/j.cca.2026.121184_bb0095","first-page":"2491","article-title":"Irisin: a potentially fresh insight into the molecular mechanisms underlying vascular aging","volume":"15","author":"Wang","year":"2023","journal-title":"Aging Dis."},{"issue":"6","key":"10.1016\/j.cca.2026.121184_bb0100","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1007\/s11255-021-03000-8","article-title":"Circulating irisin level in chronic kidney disease patients: a systematic review and meta-analysis","volume":"54","author":"Gan","year":"2022","journal-title":"Int. Urol. Nephrol."},{"issue":"5","key":"10.1016\/j.cca.2026.121184_bb0105","doi-asserted-by":"crossref","DOI":"10.1002\/cbf.70075","article-title":"Irisin is a potential novel biomarker and therapeutic target against kidney diseases","volume":"43","author":"Huang","year":"2025","journal-title":"Cell Biochem. Funct."},{"issue":"6","key":"10.1016\/j.cca.2026.121184_bb0110","article-title":"Irisin ameliorates UUO-induced renal interstitial fibrosis through TGF-\u03b21\/periostin\/MMP-2 signaling pathway","volume":"19","author":"Wang","year":"2024","journal-title":"PloS One"},{"issue":"10","key":"10.1016\/j.cca.2026.121184_bb0115","doi-asserted-by":"crossref","first-page":"e23175","DOI":"10.1096\/fj.202300420R","article-title":"Irisin ameliorates diabetic kidney disease by restoring autophagy in podocytes","volume":"37","author":"Lai","year":"2023","journal-title":"FASEB J."},{"key":"10.1016\/j.cca.2026.121184_bb0120","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41419-022-04735-7","article-title":"Irisin protects against vascular calcification by activating autophagy and inhibiting NLRP3-mediated vascular smooth muscle cell pyroptosis in chronic kidney disease","volume":"13","author":"Pang","year":"2022","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.cca.2026.121184_bb0125","doi-asserted-by":"crossref","first-page":"2610545","DOI":"10.1080\/0886022X.2025.2610545","article-title":"Irisin targets the HK1-glycolysis-NLRP3 pyroptosis axis to prevent chronic kidney disease-associated vascular calcification","volume":"47","author":"Xu","year":"2025","journal-title":"Ren. Fail."},{"issue":"1","key":"10.1016\/j.cca.2026.121184_bb0130","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s12944-022-01727-6","article-title":"Irisin protects against obesity-related chronic kidney disease by regulating perirenal adipose tissue function in obese mice","volume":"21","author":"Han","year":"2022","journal-title":"Lipids Health Dis."},{"issue":"9","key":"10.1016\/j.cca.2026.121184_bb0135","doi-asserted-by":"crossref","DOI":"10.1111\/apha.14211","article-title":"Irisin preserves mitochondrial integrity and function in tubular epithelial cells after ischemia-reperfusion-induced acute kidney injury","volume":"240","author":"Cui","year":"2024","journal-title":"Acta Physiol (Oxf.)"},{"key":"10.1016\/j.cca.2026.121184_bb0140","article-title":"Irisin pretreatment protects kidneys against acute kidney injury induced by ischemia\/reperfusion via upregulating the expression of uncoupling protein 2","volume":"2020","author":"Zhang","year":"2020","journal-title":"Biomed. Res. Int."},{"issue":"1","key":"10.1016\/j.cca.2026.121184_bb0145","doi-asserted-by":"crossref","DOI":"10.1007\/s13105-026-01159-1","article-title":"Irisin\/PGC-1-\u03b1 improves acute kidney injury by enhancing autophagy and regulating lipid metabolism","volume":"82","author":"Han","year":"2026","journal-title":"J. Physiol. Biochem."},{"issue":"7","key":"10.1016\/j.cca.2026.121184_bb0150","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1007\/s11255-023-03475-7","article-title":"Serum irisin levels and osteoporosis in patients with advanced chronic kidney disease and renal transplant recipients","volume":"55","author":"Demir","year":"2023","journal-title":"Int. Urol. Nephrol."},{"key":"10.1016\/j.cca.2026.121184_bb0155","first-page":"524","article-title":"The effect of exercise interventions on Irisin level: a systematic review and meta-analysis of randomized controlled trials","volume":"21","author":"Mohammad Rahimi","year":"2022","journal-title":"EXCLI J."},{"issue":"4","key":"10.1016\/j.cca.2026.121184_bb0160","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1136\/ebmed-2016-110401","article-title":"New evidence pyramid","volume":"21","author":"Murad","year":"2016","journal-title":"BMJ Evidence-Based Medicine"},{"issue":"11","key":"10.1016\/j.cca.2026.121184_bb0165","doi-asserted-by":"crossref","first-page":"763","DOI":"10.20344\/amp.8294","article-title":"Abordagem diagn\u00f3stica e terap\u00eautica da urtic\u00e1ria cr\u00f3nica espont\u00e2nea: recomenda\u00e7\u00f5es em Portugal","volume":"29","author":"Costa","year":"2016","journal-title":"Acta Med. Port."},{"issue":"8","key":"10.1016\/j.cca.2026.121184_bb0170","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3390\/medicina55080485","article-title":"Irisin as a multifunctional protein: implications for health and certain diseases","volume":"55","author":"Korta","year":"2019","journal-title":"Medicina"},{"key":"10.1016\/j.cca.2026.121184_bb0175","article-title":"Role of irisin in physiology and pathology","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"4","key":"10.1016\/j.cca.2026.121184_bb0180","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1210\/endrev\/bnab003","article-title":"Progress and challenges in the biology of FNDC5 and Irisin","volume":"42","author":"Maak","year":"2021","journal-title":"Endocr. Rev."},{"issue":"1","key":"10.1016\/j.cca.2026.121184_bb0185","doi-asserted-by":"crossref","DOI":"10.1002\/wsbm.1462","article-title":"Skeletal muscle: a review of molecular structure and function, in health and disease","volume":"12","author":"Mukund","year":"2020","journal-title":"Wiley Interdiscip. Rev. Syst. Biol. Med."},{"issue":"16","key":"10.1016\/j.cca.2026.121184_bb0190","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.3390\/cells14161228","article-title":"The influence of irisin on selected organs-the liver, kidneys, and lungs: the role of physical exercise","volume":"14","author":"Cialowicz","year":"2025","journal-title":"Cells"},{"issue":"7","key":"10.1016\/j.cca.2026.121184_bb0195","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.649","article-title":"Skeletal muscle: molecular structure, myogenesis, biological functions, and diseases","volume":"5","author":"Feng","year":"2020","journal-title":"MedComm"},{"key":"10.1016\/j.cca.2026.121184_bb0200","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.molmet.2020.01.016","article-title":"Irisin: still chasing shadows","volume":"34","author":"Albrecht","year":"2020","journal-title":"Mol Metab"},{"key":"10.1016\/j.cca.2026.121184_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2026.113028","article-title":"Irisin and the muscle\u2013brain axis: mechanisms and translational potential","volume":"214","author":"Arosio","year":"2026","journal-title":"Exp. Gerontol."},{"issue":"2","key":"10.1016\/j.cca.2026.121184_bb0210","doi-asserted-by":"crossref","first-page":"572","DOI":"10.7150\/ijbs.63505","article-title":"Myokine Irisin promotes osteogenesis by activating BMP\/SMAD signaling via \u03b1V integrin and regulates bone mass in mice","volume":"18","author":"Xue","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.cca.2026.121184_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2025.171439","article-title":"Potential role of integrin \u03b1V as irisin receptor and advances in research","volume":"193","author":"Bai","year":"2025","journal-title":"Peptides"},{"key":"10.1016\/j.cca.2026.121184_bb0220","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.588066","article-title":"Integrin-ligand interactions in inflammation, Cancer, and metabolic disease: insights into the multifaceted roles of an emerging ligand Irisin","volume":"8","author":"Park","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.cca.2026.121184_bb0225","doi-asserted-by":"crossref","first-page":"19502","DOI":"10.1038\/s41598-020-76524-1","article-title":"Exploring blood alterations in chronic kidney disease and haemodialysis using metabolomics","volume":"10","author":"Gagnebin","year":"2020","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.cca.2026.121184_bb0230","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jgeb.2018.06.007","article-title":"Expression, purification and biological characterisation of recombinant human irisin (12.5 kDa)","volume":"16","author":"Panati","year":"2018","journal-title":"Journal of Genetic Engineering and Biotechnology"},{"key":"10.1016\/j.cca.2026.121184_bb0235","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.peptides.2018.03.013","article-title":"Detection and quantitation of irisin in human cerebrospinal fluid by tandem mass spectrometry","volume":"103","author":"Ruan","year":"2018","journal-title":"Peptides"},{"issue":"4","key":"10.1016\/j.cca.2026.121184_bb0240","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.cmet.2015.08.001","article-title":"Detection and quantitation of circulating human irisin by tandem mass spectrometry","volume":"22","author":"Jedrychowski","year":"2015","journal-title":"Cell Metab."},{"issue":"2","key":"10.1016\/j.cca.2026.121184_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.nefro.2025.501443","article-title":"Irisin and the kidney: key points to know?","volume":"46","author":"de Almeida","year":"2026","journal-title":"Nefrolog\u00eda"},{"issue":"1","key":"10.1016\/j.cca.2026.121184_bb0250","doi-asserted-by":"crossref","DOI":"10.3390\/neurolint18010015","article-title":"The multifaceted role of irisin in neurological disorders: a systematic review integrating preclinical evidence with clinical observations","volume":"18","author":"Alzoughool","year":"2026","journal-title":"Neurol. Int."},{"key":"10.1016\/j.cca.2026.121184_bb0255","first-page":"595","article-title":"Irisin research landscape (2012\u20132024): a bibliometric and visual analysis of evolving hotspots and future trends","volume":"19","author":"Gao","year":"2025","journal-title":"Biologics"},{"issue":"1","key":"10.1016\/j.cca.2026.121184_bb0260","doi-asserted-by":"crossref","first-page":"8889","DOI":"10.1038\/srep08889","article-title":"Irisin\u2013a myth rather than an exercise-inducible myokine","volume":"5","author":"Albrecht","year":"2015","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.cca.2026.121184_bb0265","doi-asserted-by":"crossref","DOI":"10.4081\/ejtm.2023.11093","article-title":"Salivary and serum irisin in healthy adults before and after exercise","volume":"33","author":"Missaglia","year":"2023","journal-title":"Eur J Transl Myol"},{"key":"10.1016\/j.cca.2026.121184_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118954","article-title":"The \u201cirisin system\u201d: from biological roles to pharmacological and nutraceutical perspectives","volume":"267","author":"Flori","year":"2021","journal-title":"Life Sci."},{"issue":"6","key":"10.1016\/j.cca.2026.121184_bb0275","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s00431-025-06154-0","article-title":"Are breast milk and serum irisin levels affected by the BMI and nutritional status? A prospective observational study","volume":"184","author":"Yilmaz","year":"2025","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.cca.2026.121184_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2023.117756","article-title":"The role of irisin in kidney diseases","volume":"554","author":"Li","year":"2024","journal-title":"Clin. Chim. Acta"},{"issue":"1","key":"10.1016\/j.cca.2026.121184_bb0285","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1159\/000543214","article-title":"Serum irisin levels are positively correlated with physical activity capacity in hemodialysis patients","volume":"50","author":"Fan","year":"2025","journal-title":"Kidney Blood Press. Res."},{"issue":"2","key":"10.1016\/j.cca.2026.121184_bb0290","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jdiacomp.2013.09.011","article-title":"Relationship between circulating irisin, renal function and body composition in type 2 diabetes","volume":"28","author":"Liu","year":"2014","journal-title":"J. Diabetes Complications"},{"issue":"1","key":"10.1016\/j.cca.2026.121184_bb0295","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12882-015-0009-5","article-title":"Association of serum irisin and body composition with chronic kidney disease in obese Chinese adults: a cross-sectional study","volume":"16","author":"Yang","year":"2015","journal-title":"BMC Nephrol."},{"issue":"1","key":"10.1016\/j.cca.2026.121184_bb0300","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1590\/1678-4685-jbn-3802","article-title":"Does high intensity exercise affects irisin plasma levels in hemodialysis patients? A pilot study","volume":"40","author":"Esgalhado","year":"2018","journal-title":"Braz. J. Nephrol."},{"issue":"3","key":"10.1016\/j.cca.2026.121184_bb0305","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27031118","article-title":"FNDC5\/irisin: physiology and pathophysiology","volume":"27","author":"Waseem","year":"2022","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.cca.2026.121184_bb0310","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24044129","article-title":"Vitamin D increases irisin serum levels and the expression of its precursor in skeletal muscle","volume":"24","author":"Sanesi","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.cca.2026.121184_bb0315","first-page":"314","article-title":"Measurement of serum irisin in the different stages of chronic kidney disease","volume":"10","author":"Shad","year":"2019","journal-title":"Caspian J. Intern. Med."},{"issue":"2","key":"10.1016\/j.cca.2026.121184_bb0320","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.atherosclerosis.2015.08.002","article-title":"Irisin, a novel myokine is an independent predictor for sarcopenia and carotid atherosclerosis in dialysis patients","volume":"242","author":"Lee","year":"2015","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.cca.2026.121184_bb0325","doi-asserted-by":"crossref","first-page":"6052061","DOI":"10.21037\/apm-21-406","article-title":"Lower serum irisin levels are associated with the increasing mortality of cardiovascular and cerebrovascular diseases in hemodialysis patients","volume":"10","author":"Dong","year":"2021","journal-title":"Ann. Palliat. Med."},{"issue":"1","key":"10.1016\/j.cca.2026.121184_bb0330","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000535582","article-title":"Relationship between serum irisin level, all-cause mortality, and cardiovascular mortality in peritoneal dialysis patients","volume":"49","author":"Zhou","year":"2024","journal-title":"Kidney and Blood Pressure Research"},{"issue":"4","key":"10.1016\/j.cca.2026.121184_bb0335","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/j.jrn.2020.05.005","article-title":"Correlates and consequences of high serum irisin concentration in patients on hemodialysis: a longitudinal analysis","volume":"31","author":"Chiang","year":"2021","journal-title":"J. Ren. Nutr."},{"issue":"10","key":"10.1016\/j.cca.2026.121184_bb0340","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.34067\/KID.0000922022","article-title":"Peritoneal dialysis adequacy: too much of a good thing?","volume":"3","author":"Tillquist","year":"2022","journal-title":"Kidney360"},{"issue":"5","key":"10.1016\/j.cca.2026.121184_bb0345","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1159\/000517529","article-title":"Cardiometabolic effects of irisin in patients with end-stage renal disease on regular hemo-or peritoneal dialysis","volume":"51","author":"Csiky","year":"2022","journal-title":"Blood Purif."},{"key":"10.1016\/j.cca.2026.121184_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2022.111676","article-title":"Irisin reduces inflammatory signaling pathways in inflammation-mediated metabolic syndrome","volume":"552","author":"Slate-Romano","year":"2022","journal-title":"Mol. Cell. Endocrinol."},{"issue":"1","key":"10.1016\/j.cca.2026.121184_bb0355","doi-asserted-by":"crossref","first-page":"15583","DOI":"10.1038\/s41598-025-00066-7","article-title":"Irisin suppressed the progression of TBI via modulating AMPK\/MerTK\/autophagy and SYK\/ROS\/inflammatory signaling","volume":"15","author":"Zhang","year":"2025","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.cca.2026.121184_bb0360","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41392-023-01688-x","article-title":"Ischemia-reperfusion injury: molecular mechanisms and therapeutic targets","volume":"9","author":"Zhang","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"8","key":"10.1016\/j.cca.2026.121184_bb0365","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.cca.2026.121184_bb0370","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1681\/ASN.2010080798","article-title":"The inflammasomes in kidney disease","volume":"22","author":"Anders","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"issue":"23","key":"10.1016\/j.cca.2026.121184_bb0375","doi-asserted-by":"crossref","DOI":"10.3390\/molecules29235623","article-title":"Irisin attenuates neuroinflammation targeting the NLRP3 inflammasome","volume":"29","author":"Filannino","year":"2024","journal-title":"Molecules"},{"issue":"13","key":"10.1016\/j.cca.2026.121184_bb0380","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20133328","article-title":"The NLRP3 inflammasome: an overview of mechanisms of activation and regulation","volume":"20","author":"Kelley","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.cca.2026.121184_bb0385","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfaf223","article-title":"New biomarkers of inflammation associated with haemodialysis","volume":"18","author":"Guerrero","year":"2025","journal-title":"Clin. Kidney J."},{"issue":"7","key":"10.1016\/j.cca.2026.121184_bb0390","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41580-020-0230-3","article-title":"Reactive oxygen species (ROS) as pleiotropic physiological signalling agents","volume":"21","author":"Sies","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"5","key":"10.1016\/j.cca.2026.121184_bb0395","doi-asserted-by":"crossref","first-page":"F768","DOI":"10.1152\/ajprenal.00189.2023","article-title":"Mitochondrial dysfunction in the pathophysiology of renal diseases","volume":"326","author":"Guo","year":"2024","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"5","key":"10.1016\/j.cca.2026.121184_bb0400","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.bbamcr.2018.02.010","article-title":"Nrf2-Keap1 signaling in oxidative and reductive stress","volume":"1865","author":"Bellezza","year":"2018","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"issue":"1","key":"10.1016\/j.cca.2026.121184_bb0405","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s41100-018-0195-2","article-title":"Oxidative stress in chronic kidney disease","volume":"4","author":"Ling","year":"2018","journal-title":"Renal Replacement Therapy"},{"key":"10.1016\/j.cca.2026.121184_bb0410","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.857067","article-title":"Post-treatment with Irisin attenuates acute kidney injury in sepsis mice through anti-ferroptosis via the SIRT1\/Nrf2 pathway","volume":"13","author":"Qiongyue","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.cca.2026.121184_bb0415","article-title":"The time-course of antioxidant irisin activity: role of the Nrf2\/HO-1\/HMGB1 Axis","volume":"10","author":"Mazur-Bialy","year":"2021","journal-title":"Antioxidants (Basel)"},{"issue":"6","key":"10.1016\/j.cca.2026.121184_bb0420","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrneph.2016.48","article-title":"TGF-beta: the master regulator of fibrosis","volume":"12","author":"Meng","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"issue":"1","key":"10.1016\/j.cca.2026.121184_bb0425","doi-asserted-by":"crossref","first-page":"H135","DOI":"10.1152\/ajpheart.00908.2024","article-title":"Endothelial dysfunction in chronic kidney disease: a clinical perspective","volume":"329","author":"Cho","year":"2025","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"2","key":"10.1016\/j.cca.2026.121184_bb0430","doi-asserted-by":"crossref","first-page":"183","DOI":"10.23876\/j.krcp.20.163","article-title":"Implications of oxidative stress in chronic kidney disease: a review on current concepts and therapies","volume":"40","author":"Verma","year":"2021","journal-title":"Kidney Res Clin Pract"},{"issue":"2","key":"10.1016\/j.cca.2026.121184_bb0435","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4103\/tcmj.tcmj_284_24","article-title":"Endothelial dysfunction in chronic kidney disease: mechanisms, biomarkers, diagnostics, and therapeutic strategies","volume":"37","author":"Wang","year":"2025","journal-title":"Tzu Chi Med J"},{"issue":"2","key":"10.1016\/j.cca.2026.121184_bb0440","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ccc.2019.12.009","article-title":"Nitric oxide and endothelial dysfunction","volume":"36","author":"Cyr","year":"2020","journal-title":"Crit. Care Clin."},{"issue":"2","key":"10.1016\/j.cca.2026.121184_bb0445","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.atherosclerosis.2015.10.020","article-title":"Irisin protects against endothelial injury and ameliorates atherosclerosis in apolipoprotein E-Null diabetic mice","volume":"243","author":"Lu","year":"2015","journal-title":"Atherosclerosis"},{"issue":"9","key":"10.1016\/j.cca.2026.121184_bb0450","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.70767","article-title":"Irisin\/FNDC5 regulates endothelial function to improve post-stroke-induced cognitive dysfunction by stimulating AMPK-eNOS signaling","volume":"15","author":"Guo","year":"2025","journal-title":"Brain Behav."},{"key":"10.1016\/j.cca.2026.121184_bb0455","doi-asserted-by":"crossref","first-page":"1337995","DOI":"10.3389\/fendo.2024.1337995","article-title":"The emerging roles of irisin in vascular calcification","volume":"15","author":"Wang","year":"2024","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"10","key":"10.1016\/j.cca.2026.121184_bb0460","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nri2171","article-title":"Evolving functions of endothelial cells in inflammation","volume":"7","author":"Pober","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cca.2026.121184_bb0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.ceb.2024.102368","article-title":"The mitogen-activated protein kinase network, wired to dynamically function at multiple scales","volume":"88","author":"Gagliardi","year":"2024","journal-title":"Curr. Opin. Cell Biol."},{"issue":"1","key":"10.1016\/j.cca.2026.121184_bb0470","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13578-020-00413-3","article-title":"New insights into the cellular activities of Fndc5\/irisin and its signaling pathways","volume":"10","author":"Rabiee","year":"2020","journal-title":"Cell Biosci."},{"issue":"1","key":"10.1016\/j.cca.2026.121184_bb0475","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/s41392-022-01036-5","article-title":"Signaling pathways of chronic kidney diseases, implications for therapeutics","volume":"7","author":"Yuan","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.cca.2026.121184_bb0480","article-title":"Irisin enhances longevity by boosting SIRT1, AMPK, autophagy and telomerase","volume":"25","author":"Sanchez","year":"2022","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.cca.2026.121184_bb0485","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.yjmcc.2018.07.250","article-title":"Irisin alleviates pressure overload-induced cardiac hypertrophy by inducing protective autophagy via mTOR-independent activation of the AMPK-ULK1 pathway","volume":"121","author":"Li","year":"2018","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"20","key":"10.1016\/j.cca.2026.121184_bb0490","doi-asserted-by":"crossref","first-page":"7587","DOI":"10.3390\/ijms21207587","article-title":"Irisin and autophagy: first update","volume":"21","author":"Pesce","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.cca.2026.121184_bb0495","doi-asserted-by":"crossref","DOI":"10.1002\/jcsm.13810","article-title":"Transcriptional intermediary factor 1\u03b3-induced irisin in skeletal muscle attenuates renal fibrosis in diabetic nephropathy","volume":"16","author":"Kim","year":"2025","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.cca.2026.121184_bb0500","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.2147\/DMSO.S407734","article-title":"Irisin ameliorates renal tubulointerstitial fibrosis by regulating the Smad4\/beta-catenin pathway in diabetic mice","volume":"16","author":"Yang","year":"2023","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"10.1016\/j.cca.2026.121184_bb0505","doi-asserted-by":"crossref","first-page":"1675458","DOI":"10.3389\/fmed.2025.1675458","article-title":"The gut-kidney axis in chronic kidney disease: mechanisms, microbial metabolites, and microbiome-targeted therapeutics","volume":"12","author":"Alobaidi","year":"2025","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"10.1016\/j.cca.2026.121184_bb0510","article-title":"The gut-kidney axis in chronic kidney diseases","volume":"15","author":"Tsuji","year":"2024","journal-title":"Diagnostics (Basel)"},{"issue":"12","key":"10.1016\/j.cca.2026.121184_bb0515","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3390\/toxins17120599","article-title":"Targeting the gut-kidney axis: modulation of gut microbiota by traditional Chinese medicine for chronic kidney disease management","volume":"17","author":"Xin","year":"2025","journal-title":"Toxins (Basel)"},{"issue":"20","key":"10.1016\/j.cca.2026.121184_bb0520","first-page":"11532","article-title":"Indoxyl sulfate induced frailty in patients with end-stage renal disease by disrupting the PGC-1\u03b1-FNDC5 axis","volume":"15","author":"Hou","year":"2023","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.cca.2026.121184_bb0525","doi-asserted-by":"crossref","DOI":"10.1096\/fasebj.2021.35.S1.03859","article-title":"Exercise-linked FNDC5\/irisin attenuates macrophage-mediated renal inflammation in type 1 diabetes in aged mice","volume":"35","author":"Pushpakumar","year":"2021","journal-title":"FASEB J."},{"key":"10.1016\/j.cca.2026.121184_bb0530","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.redox.2018.10.019","article-title":"Irisin alleviates liver ischemia-reperfusion injury by inhibiting excessive mitochondrial fission, promoting mitochondrial biogenesis and decreasing oxidative stress","volume":"20","author":"Bi","year":"2019","journal-title":"Redox Biol."},{"issue":"7","key":"10.1016\/j.cca.2026.121184_bb0535","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2020.165792","article-title":"Irisin is induced in renal ischemia-reperfusion to protect against tubular cell injury via suppressing p53","volume":"1866","author":"Liu","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"issue":"1","key":"10.1016\/j.cca.2026.121184_bb0540","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1186\/s12964-024-01922-1","article-title":"The gut microbiome, chronic kidney disease, and sarcopenia","volume":"22","author":"Zheng","year":"2024","journal-title":"Cell Communication and Signaling"},{"issue":"3","key":"10.1016\/j.cca.2026.121184_bb0545","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s40620-022-01560-1","article-title":"Gut microbiota disturbances and protein-energy wasting in chronic kidney disease: a narrative review","volume":"36","author":"Mart\u00edn-del-Campo","year":"2023","journal-title":"J. Nephrol."},{"issue":"3","key":"10.1016\/j.cca.2026.121184_bb0550","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1067\/mcp.2001.113989","article-title":"Biomarkers and surrogate endpoints: preferred definitions and conceptual framework","volume":"69","author":"B.D.W. Group","year":"2001","journal-title":"Clin. Pharmacol. Ther. (St. Louis, MO, U. S.)"},{"issue":"10","key":"10.1016\/j.cca.2026.121184_bb0555","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.2215\/CJN.10261013","article-title":"Comparative associations of muscle mass and muscle strength with mortality in dialysis patients","volume":"9","author":"Isoyama","year":"2014","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"10","key":"10.1016\/j.cca.2026.121184_bb0560","doi-asserted-by":"crossref","DOI":"10.3390\/metabo12100939","article-title":"Impact of sustained exogenous irisin myokine administration on muscle and myocyte integrity in Sprague Dawley rats","volume":"12","author":"Alzoughool","year":"2022","journal-title":"Metabolites"},{"issue":"22","key":"10.1016\/j.cca.2026.121184_bb0565","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232214204","article-title":"Association of irisin\/FNDC5 with ERR\u03b1 and PGC-1\u03b1 expression in NSCLC","volume":"23","author":"Nowi\u0144ska","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.cca.2026.121184_bb0570","doi-asserted-by":"crossref","DOI":"10.1111\/cns.70657","article-title":"AMPK\/SIRT1\/PGC-1\u03b1 signaling pathway: molecular mechanisms and targeted strategies from energy homeostasis regulation to disease therapy","volume":"31","author":"Chen","year":"2025","journal-title":"CNS Neurosci. Ther."},{"issue":"1","key":"10.1016\/j.cca.2026.121184_bb0575","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41392-024-01756-w","article-title":"Peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) family in physiological and pathophysiological process and diseases","volume":"9","author":"Qian","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.cca.2026.121184_bb0580","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.620608","article-title":"Irisin: a new code uncover the relationship of skeletal muscle and cardiovascular health during exercise","volume":"12","author":"Ma","year":"2021","journal-title":"Front. Physiol."},{"issue":"11","key":"10.1016\/j.cca.2026.121184_bb0585","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1007\/s11255-025-04624-w","article-title":"Evidence-based practice of exercise during dialysis in maintenance hemodialysis patients","volume":"57","author":"Xiang","year":"2025","journal-title":"Int. Urol. Nephrol."},{"issue":"4","key":"10.1016\/j.cca.2026.121184_bb0590","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1258\/la.2010.0010021","article-title":"Improving bioscience research reporting: ARRIVE-ing at a solution","volume":"44","author":"Kilkenny","year":"2010","journal-title":"Lab. Anim"},{"key":"10.1016\/j.cca.2026.121184_bb0595","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"issue":"24","key":"10.1016\/j.cca.2026.121184_bb0600","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","article-title":"Canagliflozin and renal outcomes in type 2 diabetes and nephropathy","volume":"380","author":"Perkovic","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"15","key":"10.1016\/j.cca.2026.121184_bb0605","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in patients with chronic kidney disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cca.2026.121184_bb0610","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2026.178647","article-title":"Redefining SGLT2 inhibitors through cytoprotective mechanisms","volume":"1016","author":"Stankovic","year":"2026","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cca.2026.121184_bb0615","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.7754\/Clin.Lab.2015.150420","article-title":"The effects of valsartan and amlodipine on the levels of irisin, adropin, and perilipin","volume":"61","author":"Celik","year":"2015","journal-title":"Clin. Lab."},{"issue":"2","key":"10.1016\/j.cca.2026.121184_bb0620","first-page":"137","article-title":"Associations of circulating irisin with 24-h blood pressure, total and visceral fat, and metabolic parameters in young adult hypertensives","volume":"65","author":"Miazgowski","year":"2021","journal-title":"Arch Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.cca.2026.121184_bb0625","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1161\/CIRCULATIONAHA.121.055459","article-title":"Effect of the glucagon-like peptide-1 receptor agonists semaglutide and liraglutide on kidney outcomes in patients with type 2 diabetes: pooled analysis of SUSTAIN 6 and LEADER","volume":"145","author":"Shaman","year":"2022","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.cca.2026.121184_bb0630","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1007\/s11010-024-05128-4","article-title":"Resistance physical exercise modulates metabolic adipokines, decreases body weight, and improves glomerular filtration in patients with chronic kidney disease in hemodialysis","volume":"480","author":"Franscescon","year":"2025","journal-title":"Mol. Cell. Biochem."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126003669?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126003669?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T20:49:59Z","timestamp":1788900599000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898126003669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":126,"alternative-id":["S0009898126003669"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2026.121184","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Irisin as a multi-target renoprotective mediator in chronic kidney disease: from molecular mechanisms to therapeutic perspectives","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2026.121184","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"121184"}}